Inactive Instrument
Ocata Therapeutics Inc Stock
Stocks
US67457L1008
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
John Heffernan
PRN | Corporate Officer/Principal | - | 03/02/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | - | |
Masaaki Hirano
BRD | Director/Board Member | 59 | - |
Toru Yoshimitsu
BRD | Director/Board Member | 63 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.13% | +1.50% | +63.86% | +123.95% | 55.63B | |
| +6.76% | +22.83% | +91.66% | +101.42% | 52.25B | |
| +3.33% | +3.71% | -11.68% | -11.82% | 23.07B | |
| +1.32% | +9.33% | +5.28% | +419.80% | 22.41B | |
| +6.78% | +14.47% | +40.28% | -6.67% | 17.32B | |
| +0.97% | +5.01% | +31.23% | -32.10% | 15.94B | |
| -0.89% | +4.57% | +24.30% | +185.83% | 13.77B | |
| +9.96% | +19.81% | +157.65% | +320.70% | 13.47B | |
| +4.21% | +4.76% | +33.21% | - | 12.43B | |
| Average | +3.46% | +6.84% | +48.42% | +137.64% | 25.14B | |
| Weighted average by Cap. | +3.33% | +7.62% | +54.17% | +128.96% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
